[Development of a multiantigenic serological test for tuberculosis diagnosis]

Area of Science:

• Immunology
• Infectious Diseases
• Diagnostic Development

Background:

• Tuberculosis (TB) diagnosis relies on clinical, microbiological, and radiological methods.
• Serological tests for TB aim to detect antibodies against Mycobacterium tuberculosis antigens.
• Current serological assays often lack sufficient sensitivity and specificity.

Purpose of the Study:

• To evaluate a multi-antigen printing immunoassay (MAPIA) for serological diagnosis of tuberculosis.
• To determine the diagnostic accuracy of individual and combined antigens in MAPIA.
• To assess MAPIA's potential as a screening tool for TB.

Main Methods:

• Sera from 66 TB patients and 47 healthy controls were tested.
• Antibodies against 3 protein mixtures and 5 recombinant antigens were detected using MAPIA.
• Sensitivity, specificity, and predictive values were calculated and validated using logistic regression.
• Antigen combinations were optimized based on prevalence and diagnostic values.

Main Results:

• Individual antigen sensitivity ranged from 5-83% and specificity from 9-100%.
• Enriched protein mixtures demonstrated higher accuracy than individual recombinant antigens.
• Combining multiple antigens improved sensitivity to 81%, but specificity remained below 57% in most cases.

Conclusions:

• The multi-antigen printing immunoassay (MAPIA) shows potential as a screening tool for tuberculosis.
• MAPIA could complement existing definitive diagnostic methods.
• Further optimization of antigen combinations may enhance specificity for improved diagnostic utility.